Worldwide morbidity and mortality from acute myocardial infarction (AMI) and related heart failure remain high. While effective early reperfusion of the criminal coronary artery after a confirmed AMI is the typical treatment at present, collateral myocardial ischemia-reperfusion injury (MIRI) and pertinent cardioprotection are still challenging to address and have inadequately understood mechanisms. Therefore, unveiling the related novel molecular targets and networks participating in triggering and resisting the pathobiology of MIRI is a promising and valuable frontier. The present study specifically focuses on the recent MIRI advances that are supported by sophisticated bio-methodology in order to bring the poorly understood interrelationship among pro- and anti-MIRI participant molecules up to date, as well as to identify findings that may facilitate the further investigation of novel targets.
Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection
Nanbo Liu,Min Wu,Chen Chen,M. Fujino,Jing-Song Huang,P. Zhu,Xiao‐Kang Li
Published 2019 in Cardiology Research and Practice
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Cardiology Research and Practice
- Publication date
2019-05-28
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-51 of 51 citing papers · Page 1 of 1